However, these effects were abolished by LGALS3‐neutralizing antibody treatment (Figure 3A and Figure S9C, Supporting Information), suggesting that the HCC‐secreted LGALS3 induced a vicious cycle formation. Here, LGALS3 is linked to hepatocellular carcinoma.